Locations:
Search IconSearch

How Mobile Stroke Units Take Prehospital Evaluation to a New Level (Video)

Study suggests they help bypass hospital transfers for thrombectomy

18-NEU-598-Russman-Mobile-Stroke-650×450

Mobile stroke units have revolutionized many aspects of acute ischemic stroke care where they’ve been adopted, but one little-studied aspect is their potential to help bypass interhospital transfers for thrombectomy in patients with large vessel occlusions.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic researchers began to change that with a study presented at the 2018 International Stroke Conference. They retrospectively identified 50 patients who underwent thrombectomy for large vessel occlusion in 2016 or 2017 and analyzed them by mode of transport — i.e., mobile stroke unit (n = 18), conventional ambulance from Primary Stroke Center (PSC) to Comprehensive Stroke Center (CSC) (n = 19) or direct presentation at a CSC (n = 13).

They found that patients transported by mobile stroke unit were more likely to receive IV thrombolysis and had door-to-CT times, door-to-needle times and door-in-door-out times significantly shorter than those for patients initially taken to a PSC and comparable to those for patients taken directly to a CSC.

In this three-minute video, coinvestigator Andrew Russman, DO, discusses the implications of these findings and how they suggest a model where mobile stroke units may increasingly function as “mobile Primary Stroke Centers” to help bypass interhospital transfers for patients requiring thrombectomy.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad